Literature DB >> 5950829

The mechanism of the intraventricular pressure gradient in idiopathic hypertrophic subaortic stenosis.

J Ross, E Braunwald, J H Gault, D T Mason, A G Morrow.   

Abstract

Entities:  

Mesh：

Year:  1966        PMID： 5950829     DOI： 10.1161/01.cir.34.4.558

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  28 in total

1.  Intrinsic mitral valve alterations in hypertrophic cardiomyopathy sarcomere mutation carriers.

Authors:  John D Groarke; Patrycja Z Galazka; Allison L Cirino; Neal K Lakdawala; Jens J Thune; Henning Bundgaard; E John Orav; Robert A Levine; Carolyn Y Ho
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2018-10-01       Impact factor: 6.875

Review 2.  Fluid dynamic aspects of ejection in hypertrophic cardiomyopathy.

Authors:  Ares Pasipoularides
Journal:  Hellenic J Cardiol       Date:  2011 Sep-Oct

Review 3.  Nonobstructive and obstructive hypertrophic cardiomyopathies.

Authors:  J Ross; R Shabetai; G Curtis; R L Engler; D L Costello; M M LeWinter; A D Johnson; C B Higgins; G Gregoratos; J R Utley; R Shabetai
Journal:  West J Med       Date:  1979-04

4.  The systolic murmur in hypertrophic obstructive cardiomyopathy and the nature of the obstruction.

Authors:  M Nellen; M S Gotsman
Journal:  Postgrad Med J       Date:  1968-01       Impact factor: 2.401

5.  Pharmacodynamics of mitral insufficiency in muscular subaortic stenosis.

Authors:  E D Wigle; Y Marquis; P Auger
Journal:  Can Med Assoc J       Date:  1967-08-05       Impact factor: 8.262

6.  Syncope in hypertrophic obstructive cardiomyopathy due to asystole.

Authors:  S Joseph; R Balcon; L McDonald
Journal:  Br Heart J       Date:  1972-09

7.  Correlations of electrocardiographic pattern, shape of ventricular septum, and isovolumetric relaxation time in irregular hypertrophic cardiomyopathy (obstructive cardiomyopathy).

Authors:  D Harmjanz; D Böttcher; G Schertlein
Journal:  Br Heart J       Date:  1971-11

Review 8.  Obstruction is unimportant in the pathophysiology of hypertrophic cardiomyopathy.

Authors:  J M Criley; R J Siegel
Journal:  Postgrad Med J       Date:  1986-06       Impact factor: 2.401

Review 9.  Emerging pharmacologic and structural therapies for hypertrophic cardiomyopathy.

Authors:  Daniel J Philipson; Eugene C DePasquale; Eric H Yang; Arnold S Baas
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

10.  Long-term propranolol therapy in muscular subaortic stenosis.

Authors:  A G Adelman; P M Shah; R Gramiak; E D Wigle
Journal:  Br Heart J       Date:  1970-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.